Measuring psychotic depression
Year: 2013
Type: article
Abstract: OBJECTIVE: Psychotic depression (PD) is a highly debilitating condition, which needs intensive monitoring. However, there is no established rating scale for evaluating the severity of PD. The aim of this analysis was to assess the psychometric properties of established depression rating scales and a number of new composite rating scales, covering both depressive and psychotic symptoms, in relation to PD. METHOD: The psychometric properties of the rating scales were evaluated based on data from the Study of Pharmacotherapy of Psychotic Depression. RESULTS: A rating scale consisting of the 6-item Hamilton melancholia subscale (HAM-D6 ) plus five items from the Brief Psychiatric Rating Scale (BPRS), named the HAMD-BPRS11 , displayed clinical validity (Spearman's correlation coefficient between HAMD-BPRS11 and Clinical Global Impression - Severity (CGI-S) scores = 0.79-0.84), responsiveness (Spearman's correlation coefficient between change in HAMD-BPRS11 and Clinical Global Impression - Improvement (CGI-I) scores = -0.74--0.78) and unidimensionality (Loevinger's coefficient of homogeneity = 0.41) in the evaluation of PD. The HAM-D6 fulfilled the same criteria, whereas the full 17-item Hamilton Depression Scale failed to meet criteria for unidimensionality. CONCLUSION: Our results suggest that the HAMD-BPRS11 is a more valid measure than pure depression scales for evaluating the severity of PD.
Source: Acta Psychiatrica Scandinavica
DOI: 10.1111/acps.12165
Authors: S. D. Østergaard, B. S. Meyers, A. J. Flint, B. H. Mulsant, E. M. Whyte, C. M. Ulbricht, P. Bech, A. J. Rothschild, on behalf of the STOP‐PD Study Group
Institutions: Aalborg University Hospital, Aarhus University Hospital, Cornell University, University Health Network, University of Toronto, Centre for Addiction and Mental Health, University of Pittsburgh, University of Massachusetts Chan Medical School, Copenhagen University Hospital, UMass Memorial Medical Center
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Cornell ACISR for Late Life Depression, 3/4-Sustaining Remission of Psychotic Depression, 1/4-Sustaining Remission of Psychotic Depression, General Clinical Research Center, University of Pittsburgh Clinical and Translational Science Institute, G3785615859, G5418732646, University of Pittsburgh Clinical and Translational Science Institute, 4/4-Sustaining Remission of Psychotic Depression, Intervention to Prevent Post-Stroke Major Depression, Complex Trials for Severe Geriatric Mood Disorders, Clinical and Translational Science Center, 2/4-Sustaining Remission of Psychotic Depression, Clinical and Translational Science Center (UL1)
OpenAlex ID: W2166440331
